COVID-19 vaccines under regulatory scrutiny, Canada’s vaccine supply is unlikely to increase before April.The country’s rollout currently depends on vaccines from Pfizer and Moderna, both of which are in short supply amid overwhelming global demand.
Coronavirus: Toronto’s mayor speaks to Pfizer about improving COVID-19 vaccine production Canada is set to receive a combined six million doses by the end of March, enough to vaccinate three million Canadians on the vaccines’ respective two-dose regimens.Federal officials confirmed Thursday that a delay in Pfizer-BioNTech vaccine shipments to Canada will cause short-term delays across the country.